Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eiger Biopharmaceuticals (EIGRQ)
OTHER OTC:EIGRQ
Eiger Biopharmaceuticals (EIGRQ) Stock Price & Analysis
595 Followers
EIGRQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.10 - $28.50
Previous Close$13.5
Volume2.83K
Average Volume (3M)17.40K
Market Cap
$19.99M
Enterprise Value$35.79M
Total Cash (Recent Filing)$25.40M
Total Debt (Recent Filing)$41.20M
Price to Earnings (P/E)―
Beta2.36
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-50.80
Shares Outstanding1,480,797
10 Day Avg. Volume41,074
30 Day Avg. Volume17,399
Standard Deviation0.29
R-Squared0.15
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.31
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda-0.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eiger Biopharmaceuticals News
PremiumCompany Announcements
Eiger BioPharmaceuticals Announces Bankruptcy and Liquidation Plan
PremiumCompany Announcements
Eiger BioPharmaceuticals Issues Cautionary Chapter 11 Reports
PremiumCompany Announcements
Eiger BioPharmaceuticals Cautions Investors Amid BankruptcyRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EIGRQ FAQ
What was Eiger Biopharmaceuticals’s price range in the past 12 months?
Eiger Biopharmaceuticals lowest stock price was $1.10 and its highest was $28.50 in the past 12 months.
What is Eiger Biopharmaceuticals’s market cap?
Currently, no data Available
When is Eiger Biopharmaceuticals’s upcoming earnings report date?
Eiger Biopharmaceuticals’s upcoming earnings report date is Aug 08, 2024 which is in 10 days.
How were Eiger Biopharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Eiger Biopharmaceuticals overvalued?
According to Wall Street analysts Eiger Biopharmaceuticals’s price is currently Overvalued.
Does Eiger Biopharmaceuticals pay dividends?
Eiger Biopharmaceuticals does not currently pay dividends.
What is Eiger Biopharmaceuticals’s EPS estimate?
Eiger Biopharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eiger Biopharmaceuticals have?
Eiger Biopharmaceuticals has 1,480,797 shares outstanding.
What happened to Eiger Biopharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eiger Biopharmaceuticals?
Among the largest hedge funds holding Eiger Biopharmaceuticals’s share is Carlson Capital LP. It holds Eiger Biopharmaceuticals’s shares valued at N/A.
---
Eiger Biopharmaceuticals Stock Smart Score
Company Description
Eiger Biopharmaceuticals
Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of well-characterized drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.
---
EIGRQ Company Deck
---
EIGRQ Earnings Call
Q3 2022
0:00 / 0:00
---
EIGRQ Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering EIGRQ
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-28.43%
reiterated a buy rating 11 months ago
Copying Yigal Nochomovitz's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -28.43% per trade.
---